"Hjerteloeftet (HeartLift). Interaction For Preventing Cardiovascular Disease"

NACompletedINTERVENTIONAL
Enrollment

701

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

February 6, 2019

Study Completion Date

February 6, 2019

Conditions
Cardiovascular Disease
Interventions
BEHAVIORAL

Intervention (INT1)

"The course Program at the Feiring Heart Clinic will:~Clinical examination and ergospirometric testing, optimizing both treatment and prophylactic medication. Promoting physical Activity, changes in lifestyle, dietary changes/weight reduction, smoking cessation. In the follow-up period the participants will be contacted and report regularly through a web-based secure program (MedAxess)(such as: Activity-, dietary- and smoking habits). Each participant will have their own Mentor, helping keeping up the motivation. They will also meet regularly at the local doctors Office which reports relevant parameters to the Project (such as weight, BP, Lipoproteins, blood glucose/HbA1C)"

Trial Locations (1)

N-2051

LHL-Hospital Gardermoen, Jessheim

All Listed Sponsors
lead

LHL Helse

OTHER

NCT01741428 - "Hjerteloeftet (HeartLift). Interaction For Preventing Cardiovascular Disease" | Biotech Hunter | Biotech Hunter